John Abney Culberson bought Innate Immunotherapeutics (--)
John Abney Culberson (R-TX), a U.S. Representative, has disclosed 2 trades in Innate Immunotherapeutics (--) since 2017, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: John Abney Culberson bought $1,001 - $15,000 of Innate Immunotherapeutics (--) on January 26, 2017. Since that trade, -- is up +0.00% against the S&P 500 up +279.44%, an outperformance of -279.44%.
Across these filings, John Abney Culberson has been a balanced trader of -- (a buy-to-sell ratio of 1.00). The most recent disclosed -- transaction shown was dated June 2, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
John Abney Culberson's -- trades vs the price
-- is up +0.00% since John Abney Culberson bought on January 26, 2017, versus +279.44% for the S&P 500.
Performance since this trade
All John Abney Culberson -- trades
John Abney Culberson & -- trading FAQ
Is it legal for John Abney Culberson to trade Innate Immunotherapeutics (--) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Innate Immunotherapeutics (--), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did John Abney Culberson buy --?
John Abney Culberson disclosed a purchase of $1,001 - $15,000 of Innate Immunotherapeutics (--) on January 26, 2017, according to public STOCK Act filings.
How has -- performed since John Abney Culberson's trade?
Since John Abney Culberson bought -- on January 26, 2017, the stock is up +0.00%, versus +279.44% for the S&P 500 over the same period, an outperformance of -279.44%.
How many times has John Abney Culberson traded --?
John Abney Culberson has disclosed 2 -- trades since 2017 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional -- trades?
BullishWhales tracks every disclosed congressional trade in Innate Immunotherapeutics (--) on the Innate Immunotherapeutics congressional trading page, which aggregates filings across all members of Congress.
John Abney Culberson's -- tradesAll congressional filings for Innate ImmunotherapeuticsJohn Abney Culberson's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.